Moreover, due to the peripheral action of GLP-1, their use in depressed patients may also prevent the development of metabolic diseases, such as diabetes and obesity, which are often associated with a depressive disorder. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.